MyoRing treatment of myopia

INTRODUCTION: Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the treatment was to be spectacle independent in everyday-life. MATERIALS AND METHODS: 19 myopic eyes of 12 patients ranging from −2.25 to −16.5 dioptres (D) in sphere and from 0 to −4 D in cylinder were analyzed. RESULTS: After treatment, 84% of the eyes reached uncorrected distance visual acuity (UDVA) of 0.5 or better, 42% reached UDVA of 0.8 or better and 16% reached UDVA of 1.0 or better. Before treatment, no eye reached UDVA of 0.5 or better. Corrected distance visual acuity (CDVA) preoperatively and postoperatively did not differ. The treatment changed the average spherical equivalent from −10.27 D to −0.93 D. Efficacy index was 0.76 and safety index was 1.02. CONCLUSION: MyoRing implantation for myopia is safe and effective with highly satisfied patents in a particular subgroup of myopic patients. Patient selection is important.